In a research report sent to investors, Canaccord Genuity analyst Mark Massaro downgraded shares of Venaxis (NASDAQ:APPY) from Buy to Hold, and reduced the …
Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Venaxis Inc (NASDAQ:APPY) with a $5.00 price target, which represents a potential upside …
